Achieve Life Sciences opened lower at $6.42, compared with its previous close of $6.45. In the last trading session, the stock traded between $6.20 and $6.50. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Achieve Life Sciences is now worth
$ 75.46
Resulting in a loss of
$ 24.54 (24.54%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 5 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-0.17 (-2.67%)
Day High
$6.50
Day Low
$6.20
Day Open
$6.42
Prev Close
$6.45
Volume
6,44,734
1W Return
-10.12%
1M Return
-11.03%
3M Return
-7.38%
6M Return
12.31%
1Y Return
31.61%
Fundamentals
Market Cap ($ Mn)
646
PE Ratio
-
PB Ratio
-
PEG Ratio
-
ROE
-213.50%
ROCE
-155.79%
EPS (TTM)
$-0.73
Investment Returns
1 Week
-10.12%
1 Month
-11.03%
3 Months
-7.38%
6 Months
12.31%
9 Months
46.68%
Financials
Quarterly
All values in $ Mn
0.0
Dec 24
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
0.0
Jun 26
Updates
10Nov
Achieve Life Sciences Q3 Results: EPS loss narrows 60.71% YoY to $(0.11)
Achieve Life Sciences posted a Q3 loss of $(0.11) per share. The figure beat the analyst consensus estimate of $(0.20) by 45%. Year-over-year losses narrowed by 60.71% from $(0.28).
2 days ago
2Nov
Achieve Life Sciences grants 97k option and RSU awards to new hires
Approved 97,000 stock options and 97,000 RSUs for three new employees. Awards issued under the 2024 Equity Inducement Plan per Nasdaq Rule 5635(c)(4). Stock options vest over four years with a 25% one-year cliff. RSUs vest annually over four years subject to continued service.
10 days ago
4Sep
Achieve Life Sciences grants 598,000 equity awards to seven new hires
Achieve Life Sciences granted 315,000 stock options and 283,000 RSUs to seven new hires. Awards were approved under the 2024 Equity Inducement Plan on Sept. 3, 2026. Stock options vest 25% at year one, with the balance monthly over three years. RSUs vest 25% annually over four years, contingent on continued service.
2mo ago
15Aug
Achieve Life Sciences enters $150m ATM stock sale agreement with Jefferies
Achieve Life Sciences secured an ATM equity offering agreement with Jefferies for up to $150 million in common stock. The deal, filed with the SEC, provides the company with a flexible capital raising tool. Jefferies serves as the placement agent for the transaction.
3mo ago
11Aug
Achieve Life Sciences Q2 Results: EPS misses estimate, losses widen
Achieve Life Sciences missed Q2 EPS estimates with a loss of $(0.80), down 400% from the $(0.16) forecast. Year-over-year losses widened 116.22% from $(0.37), signaling deteriorating profitability trends that may impact investor confidence and future analyst models.
3mo ago
31Jul
Achieve Life Sciences grants equity awards to six new hires
Achieve Life Sciences granted 1.19 million stock options and 125,000 RSUs to six new employees under its 2024 Equity Inducement Plan. The awards vest over four years and comply with Nasdaq Listing Rule 5635(c)(4), supporting recruitment for its cytisinicline development program.
